Crown Princess Mette-Marit Awaiting Double Lung Transplant Amid Health Crisis

The Norwegian Royal Family has announced that Crown Princess Mette-Marit is now on the waiting list for a lung transplant, following a significant decline in her health due to pulmonary fibrosis. The hereditary disease, characterized by the development of scar tissue in the lungs that impairs breathing, has been affecting the Crown Princess for several years. Recent medical evaluations have determined that without a transplant, her prognosis is limited to approximately one year.

The medical team at Oslo's Rikshospitalet, Norway's largest university hospital, is overseeing the Crown Princess's care. Chief physician and pulmonology specialist Are Holm provided detailed information during a press conference regarding the process and potential risks associated with a lung transplant. According to Holm, the procedure planned for Mette-Marit involves replacing both lungs, which is standard for patients with advanced pulmonary fibrosis.

The complexity of the operation lies primarily in the removal of the diseased lungs. In some cases, the lungs can be fused with surrounding tissues or present certain anatomical challenges, increasing the risk of complications such as bleeding or the need for additional surgical interventions. These factors contribute to the overall risk profile for patients undergoing this type of surgery.

Placement on the transplant waiting list comes with strict requirements. Patients must remain within Norway and be readily available for immediate contact should a suitable donor organ become available. They are also required to report any infections or health changes, as these factors influence eligibility for surgery. Additionally, they must attempt to maintain their physical condition to the best of their ability.

The selection criteria for a donor lung are stringent. The organ must be a suitable size, match the recipient's blood group, and be free from antibodies that could provoke a rejection response. The identity of the donor remains strictly confidential under Norwegian law, which prohibits any attempt to discover or disclose personal information that could connect the donor and recipient. The hospital reiterated the importance of maintaining the anonymity and privacy of both parties throughout the transplantation process.

Medical experts addressed concerns regarding the recurrence of pulmonary fibrosis following transplantation. While some diseases can reappear in new organs, current evidence indicates that pulmonary fibrosis generally does not recur in transplanted lungs, offering hope for improved quality of life post-operation.

The urgency of the transplant is determined by the severity of the patient's condition rather than by status or public profile. The hospital team emphasized that the allocation of donor organs is based solely on medical necessity, with no preference given due to royal status. This protocol aims to ensure fairness and transparency in organ distribution, particularly given the limited availability of suitable donor lungs.

Family members have been closely involved during this period. The Crown Princess's daughter has traveled from Australia to be at her side, while her son, who is currently in custody, unsuccessfully applied for a temporary release to visit her. All of Mette-Marit's scheduled public appearances have been canceled as her medical team continues to monitor her condition and readiness for potential surgery.

The exact timing of the transplant remains uncertain, as it depends on the availability of a compatible donor and the urgency of the patient's medical situation. Norwegian authorities do not announce the date of such surgeries in advance in order to preserve donor anonymity. The medical team remains in close contact with the royal family and will continue to provide updates as appropriate, while maintaining strict adherence to privacy regulations.